be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...

All articles

Filters:

Show search box

2016-03-29

Teichoic acids inhibitors in antibiotic recycling

Teichoic acids inhibitors in antibiotic recycling

Current „boom” for new inhibitors of wall teichoic acids (WTA) of gram-positive bacteria has recently brought another scientific achievement. Tarocin A and B are novel compounds, which not having bactericidal action on their own, restore activity of several β-lactam antibiotics against methicillin-re... Read more

Tags antibiotics , WTA , wall teichoic acids , MRSA , MRSE , tarocin